André F E
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S419-23. doi: 10.1093/clinids/6.supplement_2.s419.
This article reviews the epidemiologic impact of the immunization policies in Belgium since the time efficacious vaccines became available, including recent serologic and virologic surveys as well as evidence for the relative effectiveness of inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine ( OPV ) in routine immunization programs. Poliomyelitis as an indigenous disease has disappeared in Belgium since the late 1960s as a result of immunization with IPV from 1958 to 1969 and with OPV since 1963. In the immediate prevaccine era, the annual average number of cases of paralytic poliomyelitis per million inhabitants was 37 between 1951 and 1954 and 71 between 1955 and 1958, with a peak of 1,038 cases in 1956. Soon after the initial successful control of poliomyelitis in the early 1960s, the acceptance rate of vaccination decreased. In order for a high level of immunity to the disease in the population to be maintained, immunization of children before the age of 18 months was made compulsory by Royal Decree on January 1, 1967.
本文回顾了自有效疫苗问世以来,比利时免疫政策的流行病学影响,包括近期的血清学和病毒学调查,以及灭活脊髓灰质炎疫苗(IPV)和口服脊髓灰质炎疫苗(OPV)在常规免疫计划中的相对有效性证据。由于1958年至1969年使用IPV以及自1963年以来使用OPV进行免疫接种,脊髓灰质炎作为一种本土疾病在比利时自20世纪60年代末起已消失。在疫苗接种前的时代,1951年至1954年间每百万居民中麻痹性脊髓灰质炎的年平均病例数为37例,1955年至1958年间为71例,1956年达到峰值1038例。在20世纪60年代初首次成功控制脊髓灰质炎后不久,疫苗接种的接受率下降。为了在人群中维持对该疾病的高免疫力水平,1967年1月1日皇家法令规定对18个月以下儿童进行强制免疫接种。